These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 23828385

  • 21. Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single-arm, exploratory phase II trial.
    Tang Q, Zhang X, Zhu X, Xu H, Song G, Lu J, Wu H, Deng C, Ai F, Zhang Y, Wang J.
    Cancer Med; 2024 Sep; 13(18):e70206. PubMed ID: 39324173
    [Abstract] [Full Text] [Related]

  • 22. An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma.
    Rosen G.
    Cancer Treat Res; 1993 Sep; 62():49-54. PubMed ID: 8096759
    [No Abstract] [Full Text] [Related]

  • 23. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
    Bajpai J, Chandrasekharan A, Talreja V, Simha V, Chandrakanth MV, Rekhi B, Khurana S, Khan A, Vora T, Ghosh J, Banavali SD, Gupta S.
    Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
    [Abstract] [Full Text] [Related]

  • 24. [Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
    Punanov IuA, Gafton GI, Gudz' IuV, Nabokov VV, Ivanova TV, Safonova SA, Levchenko EV, Kupatadze DD, Novik VI, Lazareva IuR, Krzhivitskiĭ PI, Petrov VG.
    Vopr Onkol; 2012 Nov; 58(2):275-81. PubMed ID: 22774537
    [Abstract] [Full Text] [Related]

  • 25. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W, Tang L, Lin F, Yao Y, Shen Z.
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [Abstract] [Full Text] [Related]

  • 26. Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults.
    Patel SJ, Lynch JW, Johnson T, Carroll RR, Schumacher C, Spanier S, Scarborough M.
    Am J Clin Oncol; 2002 Oct; 25(5):489-95. PubMed ID: 12393991
    [Abstract] [Full Text] [Related]

  • 27. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G, Longhi A, Forni C, Fabbri N, Briccoli A, Barbieri E, Mercuri M, Balladelli A, Ferrari S, Picci P.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):505-11. PubMed ID: 17118571
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
    Cohen IJ.
    Pediatr Hematol Oncol; 2003 Dec 01; 20(8):579-81. PubMed ID: 14578026
    [Abstract] [Full Text] [Related]

  • 32. Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study.
    Gaspar N, Occean BV, Pacquement H, Bompas E, Bouvier C, Brisse HJ, Castex MP, Cheurfa N, Corradini N, Delaye J, Entz-Werlé N, Gentet JC, Italiano A, Lervat C, Marec-Berard P, Mascard E, Redini F, Saumet L, Schmitt C, Tabone MD, Verite-Goulard C, Le Deley MC, Piperno-Neumann S, Brugieres L, SFCE (Société Française des Cancers de l'Enfant et l'adolescent), GSF-GETO (Groupe Sarcome Français), UNICANCER sarcoma group.
    Eur J Cancer; 2018 Jan 01; 88():57-66. PubMed ID: 29190507
    [Abstract] [Full Text] [Related]

  • 33. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
    Samardziski M, Zafiroski G, Tolevska C, Zafirova-Ivanovska B, Kostadinova-Kunovska S, Kalicanin-Markovska M.
    J BUON; 2009 Jan 01; 14(1):63-9. PubMed ID: 19373949
    [Abstract] [Full Text] [Related]

  • 34. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
    Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Körholz D, Graf N, Heise U, Jürgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K.
    Ann Oncol; 1998 Aug 01; 9(8):893-9. PubMed ID: 9789613
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86).
    Winkler K, Bielack S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, Jürgens H, Ritter J, Kusnierz-Glaz C, Erttmann R.
    Cancer; 1990 Oct 15; 66(8):1703-10. PubMed ID: 2208024
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.